Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 66856

48 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
November 01, 2013
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Natures Pharmacy & Compounding Center

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

48 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 48

Lidocaine 4% Urethral Gel

D-1098-2014
Recall number
D-1098-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
104 syringes

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

Lot# 101213, Exp. 04/14 Lot# 09202013, Exp. 03/14 Lot# 08272013, Exp. 02/14 Lot# 08022013, Exp. 01/14

Distribution pattern

NC

drug · product 2 of 48

Acetylcysteine 10% ophthalmic

D-1099-2014
Recall number
D-1099-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 3 of 48

AMP/M-B12/Pyridox/Methionine Inositol

D-1100-2014
Recall number
D-1100-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 4 of 48

Bladder Instillation

D-1101-2014
Recall number
D-1101-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 5 of 48

Bleomycin Sulfate 1unit/ml

D-1102-2014
Recall number
D-1102-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 6 of 48

Cyanocobalamin 100mcg/ml injection

D-1103-2014
Recall number
D-1103-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 7 of 48

Cyano B-12 p-f 1000mcg/ml

D-1104-2014
Recall number
D-1104-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 8 of 48

Cyano B-12 (Cmpd) 1000mcg/ml

D-1105-2014
Recall number
D-1105-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 9 of 48

Dexamethasone (pf) 0.05 % opth.

D-1106-2014
Recall number
D-1106-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 10 of 48

Dexamethosone/Tobramycin pf 0.1%/0.3% ophthalmic

D-1107-2014
Recall number
D-1107-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 11 of 48

Dexamethasone phosphate 24mg/ml inj.

D-1108-2014
Recall number
D-1108-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 12 of 48

Estradiol Cypionate 2mg/cc testosterone cypionoate 50mg

D-1109-2014
Recall number
D-1109-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 13 of 48

Ethanol 20% ophthal.

D-1110-2014
Recall number
D-1110-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 14 of 48

EDTA 3% ophthalmic

D-1111-2014
Recall number
D-1111-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 15 of 48

5-Fluorouracil pf in methocel 1% opthal

D-1112-2014
Recall number
D-1112-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 16 of 48

5-Fluorouracil 1% ophthal

D-1113-2014
Recall number
D-1113-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 17 of 48

Folic acid (pf) 10mg/cc inj

D-1114-2014
Recall number
D-1114-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 18 of 48

Gentamycin 80mg/1000cc 0.9% NS

D-1115-2014
Recall number
D-1115-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 19 of 48

L-Glutathione inhalation

D-1116-2014
Recall number
D-1116-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 20 of 48

Glutathione 6%/ascorbic 1%/DMSO 6.25%

D-1117-2014
Recall number
D-1117-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 21 of 48

Glutathione 1.25%/Ascorbic 1.25%/DMSO 6.25%

D-1118-2014
Recall number
D-1118-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 22 of 48

Glutathione Inhalation 200mg/5ml

D-1119-2014
Recall number
D-1119-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 23 of 48

Hydroxocobalamin inj.

D-1120-2014
Recall number
D-1120-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 24 of 48

Hydroxyprogesterone Caproate

D-1121-2014
Recall number
D-1121-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 25 of 48

Idoxuridine 0.1% Ophthalmic

D-1122-2014
Recall number
D-1122-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 26 of 48

Methotrexate Intraocular 400mcg 0.1cc

D-1123-2014
Recall number
D-1123-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 27 of 48

Methylcobalamin

D-1124-2014
Recall number
D-1124-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 28 of 48

Novarel (IM)

D-1125-2014
Recall number
D-1125-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 29 of 48

Papaverine 1nj 30mg/ml

D-1126-2014
Recall number
D-1126-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 30 of 48

Papaverine 12mg/phent 1mg/Pros 9mcq/ml

D-1127-2014
Recall number
D-1127-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 31 of 48

Prostaglandin all combinations

D-1128-2014
Recall number
D-1128-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 32 of 48

Pyridoxine (p-f) 100mg/ml

D-1129-2014
Recall number
D-1129-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 33 of 48

Renacidin Irrigation

D-1130-2014
Recall number
D-1130-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 34 of 48

Sodium Bicarbonate 8.4% inj.

D-1131-2014
Recall number
D-1131-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 35 of 48

Scopolamine 0.25 opth.

D-1132-2014
Recall number
D-1132-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 36 of 48

Tetracaine 0.5% ophth.

D-1133-2014
Recall number
D-1133-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 37 of 48

Tacrolimus (H20-based) 0.03% ophth.

D-1134-2014
Recall number
D-1134-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 38 of 48

Tacrolimus 0.02% opth. (H20-based)

D-1135-2014
Recall number
D-1135-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 39 of 48

Terbutaline/Ipratropium 0.5mg/2.5ml

D-1136-2014
Recall number
D-1136-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 40 of 48

Testosterone Cypionate 100mg/ml

D-1137-2014
Recall number
D-1137-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 41 of 48

Testosterone Cypionate 200mg/ml

D-1138-2014
Recall number
D-1138-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 42 of 48

Triamcinolone Acetonide 3mg/ml

D-1139-2014
Recall number
D-1139-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 43 of 48

Vancomycin (fortified) 25mg/ml opth

D-1140-2014
Recall number
D-1140-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 44 of 48

Vit A (olive oil) 0.1% opth.

D-1141-2014
Recall number
D-1141-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 45 of 48

Vitamin D (Ergocalciferol) 800 u/ml

D-1142-2014
Recall number
D-1142-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 46 of 48

Voriconazole 1% opthal

D-1143-2014
Recall number
D-1143-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 47 of 48

Voriconazole 0.5mg/ml

D-1144-2014
Recall number
D-1144-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

drug · product 48 of 48

Voriconazole 0.5mg/ml

D-1145-2014
Recall number
D-1145-2014
Initiated
November 01, 2013
Classification
Class II
Status
Terminated
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Code information

All lot numbers within expiry.

Distribution pattern

NC

Field note

Send feedback

We'll only use this to respond to your feedback.